Skip to content

Evaluate the Safety and Effectiveness of Various Frequency Stimulation for Patients With Parkinson's Disease

Evaluate the Safety and Effectiveness Between Various Frequency Stimulation and Traditional High Frequency Stimulation for the Treatment of Patients With Parkinson's Disease

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02929628
Enrollment
106
Registered
2016-10-11
Start date
2016-12-31
Completion date
2017-11-30
Last updated
2016-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Brief summary

Patients with an implantable electrical nerve stimulation system Patient criteria included: over 18 years of age,MMSE≥ 24 score; H-Y stage in medicine off condition\>2.0;an ability to walk at least 10 meters independently;subscore≥2 for UPDRS part II item 15;subscore \>1 for UPDRS part II item 14; permissions given by informed consent. Patients with serious diseases such as tumor, sever liver or kidney dysfunction were not selected in the clinical trials. Subjects participating in other clinical trials related or not related to these trials were not chosen.

Interventions

DEVICEBeijing PINS Programming

Using the programming control the Stimulator to change the parameter

Sponsors

Beijing Pins Medical Co., Ltd
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age \>18 years of age,male or female patients * idiopathic Parkinson's disease * had deep brain stimulaton implant * H-Y\>2.0 in the absence of L-dopa * UPDRSII-14 item ≥1 * UPDRSII-15 item ≥2 * an ability to walk at least 10 meters independently

Exclusion criteria

* Patients with serious diseases such as tumor, sever liver or kidney dysfunction were not selected in the clinical trials * epilepsy * Pregnant female * History of severe neuropsychiatric disease * Patients are taking part in other clinical trials in recent several months

Design outcomes

Primary

MeasureTime frame
Changs in the score of Stand-Walk-Sit Test1、3、6 and 12 month

Secondary

MeasureTime frame
Change of the score in UPDRS1,3,6,12 months of Various Frequency Stimulation
Change of the score in PDQ-391、3、6、12 months of Various Frequency Stimulation
Change of the score in the FOG-Q1、3、6、12 month of Various Frequency Stimulation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026